[go: up one dir, main page]

ITMI20060629A1 - Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento - Google Patents

Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento

Info

Publication number
ITMI20060629A1
ITMI20060629A1 IT000629A ITMI20060629A ITMI20060629A1 IT MI20060629 A1 ITMI20060629 A1 IT MI20060629A1 IT 000629 A IT000629 A IT 000629A IT MI20060629 A ITMI20060629 A IT MI20060629A IT MI20060629 A1 ITMI20060629 A1 IT MI20060629A1
Authority
IT
Italy
Prior art keywords
adenosylmetionine
achievement
solid compositions
compositions based
oral solid
Prior art date
Application number
IT000629A
Other languages
English (en)
Inventor
Marco Berna
Angelis Carlo De
Daniele Giovannone
Original Assignee
Daniele Giovannone
Gnonis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daniele Giovannone, Gnonis Spa filed Critical Daniele Giovannone
Priority to IT000629A priority Critical patent/ITMI20060629A1/it
Priority to HUE06780609A priority patent/HUE047955T2/hu
Priority to NZ571240A priority patent/NZ571240A/en
Priority to CN2006800541063A priority patent/CN101415464B/zh
Priority to RSP-2008/0441A priority patent/RS20080441A/sr
Priority to PL06780609T priority patent/PL2007479T3/pl
Priority to DK06780609.1T priority patent/DK2007479T3/da
Priority to MEP-227/08A priority patent/MEP22708A/xx
Priority to SI200632369T priority patent/SI2007479T1/sl
Priority to AU2006341243A priority patent/AU2006341243B2/en
Priority to MEP-2008-227A priority patent/ME00115B/me
Priority to RS20200221A priority patent/RS59995B1/sr
Priority to EP06780609.1A priority patent/EP2007479B1/en
Priority to MX2008012491A priority patent/MX2008012491A/es
Priority to CA2645767A priority patent/CA2645767C/en
Priority to HRP20200315TT priority patent/HRP20200315T1/hr
Priority to PCT/IT2006/000610 priority patent/WO2007113885A2/en
Priority to BRPI0621556A priority patent/BRPI0621556B8/pt
Priority to ZA200808118A priority patent/ZA200808118B/xx
Priority to EA200802095A priority patent/EA017895B1/ru
Priority to JP2009502342A priority patent/JP5562632B2/ja
Priority to ES06780609T priority patent/ES2774913T3/es
Publication of ITMI20060629A1 publication Critical patent/ITMI20060629A1/it
Priority to IL194254A priority patent/IL194254A/en
Priority to US12/240,002 priority patent/US20090110729A1/en
Priority to US14/718,789 priority patent/US10471088B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IT000629A 2006-03-31 2006-03-31 Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento ITMI20060629A1 (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
IT000629A ITMI20060629A1 (it) 2006-03-31 2006-03-31 Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
RS20200221A RS59995B1 (sr) 2006-03-31 2006-08-08 Čvrsti oralni preparati na bazi soli s-adenozil metionina i postupak njihovog dobijanja
MX2008012491A MX2008012491A (es) 2006-03-31 2006-08-08 Composiciones orales solidas basadas en s-adenosil-metionina y/o nadh, y proceso para su obtencion.
CN2006800541063A CN101415464B (zh) 2006-03-31 2006-08-08 基于s-腺苷甲硫氨酸和/或nadh的固体口服组合物和其获得方法
RSP-2008/0441A RS20080441A (sr) 2006-03-31 2006-08-08 Čvrste oralne kompozicije bazirane na s-adenozil metioninu i/ili nadh i proces za njihovo dobijanje
PL06780609T PL2007479T3 (pl) 2006-03-31 2006-08-08 Stałe kompozycje doustne na bazie soli s-adenozylometioniny i sposób ich otrzymywania
DK06780609.1T DK2007479T3 (da) 2006-03-31 2006-08-08 Faste orale sammensætninger baseret på S-adenosyl-methioninsalt og fremgangsmåde til opnåelse deraf
MEP-227/08A MEP22708A (en) 2006-03-31 2006-08-08 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
SI200632369T SI2007479T1 (sl) 2006-03-31 2006-08-08 Trdni peroralni sestavki na osnovi soli S-adenozil metionina in proces za njihovo pridobivanje
AU2006341243A AU2006341243B2 (en) 2006-03-31 2006-08-08 Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them
MEP-2008-227A ME00115B (me) 2006-03-31 2006-08-08 Čvrste oralne kompozicije bazirane na s-adezonil metionin i/ili nadh i proces za njihovo dobijanje
HUE06780609A HUE047955T2 (hu) 2006-03-31 2006-08-08 S-adenozil metioninsó alapú szilárd orális készítmények és eljárás azok elõállítására
EP06780609.1A EP2007479B1 (en) 2006-03-31 2006-08-08 Solid oral compositions based on S-adenosyl methionine salt and process for obtaining them
HRP20200315TT HRP20200315T1 (hr) 2006-03-31 2006-08-08 Čvrsti oralni pripravci na bazi soli s-adenozilmetionina i postupak njihove priprave
CA2645767A CA2645767C (en) 2006-03-31 2006-08-08 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
JP2009502342A JP5562632B2 (ja) 2006-03-31 2006-08-08 S−アデノシルメチオニンおよび/またはnadhをベースにした固形経口組成物およびそれを得る方法
PCT/IT2006/000610 WO2007113885A2 (en) 2006-03-31 2006-08-08 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
BRPI0621556A BRPI0621556B8 (pt) 2006-03-31 2006-08-08 composição, processo para a preparação de um tablete, composições, uso de s-adenosil metionina sulfato paratolueno sulfonato ou s-adenosil metionina-1,4-buteno dissulfonato, em associação com óxido de cálcio, e método para estabilizar uma composição baseada em s-adenosil metionina sulfato paratolueno sulfonato ou s-adenosil metionina-1,4-buteno dissulfonato
ZA200808118A ZA200808118B (en) 2006-03-31 2006-08-08 Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them
EA200802095A EA017895B1 (ru) 2006-03-31 2006-08-08 ТВЕРДЫЕ ПРИНИМАЕМЫЕ ВНУТРЬ ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НА ОСНОВЕ S-АДЕНОЗИЛМЕТИОНИНА (SAMe) ИЛИ НИКОТИНАМИДАДЕНИНДИНУКЛЕОТИДА (NADH) И СПОСОБ ИХ ПОЛУЧЕНИЯ
NZ571240A NZ571240A (en) 2006-03-31 2006-08-08 Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them
ES06780609T ES2774913T3 (es) 2006-03-31 2006-08-08 Composiciones orales sólidas a base de sal de S-adenosil metionina y procedimiento para la obtención de las mismas
IL194254A IL194254A (en) 2006-03-31 2008-09-22 S-adenosyl methionine or nadh-based compositions, methods of preparation and use thereof in the preparation of antidepressants
US12/240,002 US20090110729A1 (en) 2006-03-31 2008-09-29 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
US14/718,789 US10471088B2 (en) 2006-03-31 2015-05-21 Solid oral compositions based on S-adenosyl methionine and/or NADH and process for obtaining them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000629A ITMI20060629A1 (it) 2006-03-31 2006-03-31 Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento

Publications (1)

Publication Number Publication Date
ITMI20060629A1 true ITMI20060629A1 (it) 2007-10-01

Family

ID=37327762

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000629A ITMI20060629A1 (it) 2006-03-31 2006-03-31 Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento

Country Status (22)

Country Link
US (2) US20090110729A1 (it)
EP (1) EP2007479B1 (it)
JP (1) JP5562632B2 (it)
CN (1) CN101415464B (it)
AU (1) AU2006341243B2 (it)
BR (1) BRPI0621556B8 (it)
CA (1) CA2645767C (it)
DK (1) DK2007479T3 (it)
EA (1) EA017895B1 (it)
ES (1) ES2774913T3 (it)
HR (1) HRP20200315T1 (it)
HU (1) HUE047955T2 (it)
IL (1) IL194254A (it)
IT (1) ITMI20060629A1 (it)
ME (2) ME00115B (it)
MX (1) MX2008012491A (it)
NZ (1) NZ571240A (it)
PL (1) PL2007479T3 (it)
RS (2) RS20080441A (it)
SI (1) SI2007479T1 (it)
WO (1) WO2007113885A2 (it)
ZA (1) ZA200808118B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115708820A (zh) * 2023-01-09 2023-02-24 广东科泰鼎润药业科技有限公司 L-茶氨酸缓释制剂、双释放制剂、应用和药物

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
SMT202000179T1 (it) 2008-08-15 2020-05-08 Ironwood Pharmaceuticals Inc Formulazioni contenenti linaclotide per la somministrazione orale
EP2189154A1 (en) 2008-11-25 2010-05-26 Gnosis S.p.A. Effervescent tablets and mouth-soluble granulates of S-adenosyl methionine and process for the preparation thereof
IT1393331B1 (it) * 2009-02-09 2012-04-20 Graal S R L Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same)
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
WO2012012902A1 (en) * 2010-07-28 2012-02-02 Msi Methylation Sciences Inc. S-adenosylmethionine formulations with enhanced bioavailability
MX2012001660A (es) * 2009-08-06 2012-03-26 Ironwood Pharmaceuticals Inc Formulaciones que contienen linaclotida para adminstracion oral.
WO2011103311A2 (en) 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc Treatments for gastrointestinal disorders
JP5921545B2 (ja) 2010-08-11 2016-05-24 アイアンウッド ファーマシューティカルズ インコーポレイテッド リナクロチドの安定な製剤
EA201100309A1 (ru) * 2011-03-03 2011-08-30 Екофарм Патент Менеджмент Аг Фармацевтическая композиция, стимулирующая биосинтез s-аденозилметионина, и пероральное лекарственное средство
TR201103625A1 (tr) * 2011-04-14 2012-12-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Sefuroksim içeren tablet formülasyonu üretim prosesi.
PL2776055T3 (pl) 2011-08-17 2017-06-30 Ironwood Pharmaceuticals, Inc. Sposoby leczenia zaburzeń żołądkowo-jelitowych
ES2540581T3 (es) 2012-10-17 2015-07-10 Methylation Sciences International Srl Composiciones que comprenden S-adenosilmetionina y un éster de ácido gálico
ITMI20131906A1 (it) 2013-11-18 2015-05-19 Gnosis Spa Composizioni solide orali a lento rilascio
PL3344273T3 (pl) * 2015-08-31 2020-06-01 Nutramax Laboratories, Inc. Kompozycje zawierające magnolię, korkowiec, teaninę i/lub białko serwatkowe
IT202000006127A1 (it) * 2020-03-23 2021-09-23 Fmc S R L Formulazione farmaceutica, dietetica e/o alimentare a base ademetionina e processo di realizzazione di detta formulazione
CN121218887A (zh) 2023-05-15 2025-12-26 博纳菲德健康有限公司 睡眠改善组合物和使用方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3012943A (en) * 1958-11-18 1961-12-12 Nutrilite Products Vitamin c concentrate
US3330729A (en) * 1963-10-04 1967-07-11 Goodrich Co B F Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent
IE37913B1 (en) * 1972-08-02 1977-11-09 Bioresearch Sas Salt of s-adenosyl-l-methionine
IE39517B1 (en) * 1973-06-27 1978-10-25 Bioresearch Sas Double salts of s-adenosyl-l-methhionine
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
CA1187388A (en) * 1978-09-20 1985-05-21 American Monitor Corporation Stabilization of working reagent solutions containing nadh, nadph, and/or enzymes, and the use of such stabilized reagents in enzymes or substrate assays
GB2064523B (en) * 1979-12-04 1983-06-29 Kanegafuchi Chemical Ind Stable composition of s-adenosyl-l-methionine
US4394449A (en) * 1980-02-13 1983-07-19 Modrovich Ivan Endre Stabilization of coenzymes in aqueous solution
IT1137640B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1139974B (it) * 1981-09-11 1986-09-24 Bioresearch Srl Derivati della s-adenosilmetionina,processo per la preparazione e composizioni terapeutiche che li contengono come principio attivo
JPS60181095A (ja) * 1984-02-27 1985-09-14 Nippon Zeon Co Ltd S−アデノシル−l−メチオニン含有組成物及びその製造法
IT1173991B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Composizioni farmaceutiche comprendenti solfo-afenosil-l-metionina (same) particolarmente adatte per uso orale e per supposte
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
US4870059A (en) * 1985-11-27 1989-09-26 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Dehydration of hydrous matter with anhydrous maltose
US4704365A (en) * 1986-02-24 1987-11-03 Abbott Laboratories Composition and method for stabilization of dinucleotides
JPH0291018A (ja) * 1988-09-27 1990-03-30 Farval Ag 湿気に対して安定な固形バルプロ酸製剤とその製造法
US6451341B1 (en) * 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
IT1243859B (it) * 1990-10-23 1994-06-28 Bioresearch Spa Composizioni farmaceutiche comprendenti associazioni fra sali di s-adenosil-l-metionina e acido 5-metil (o 5-formil)-tetraidrofolico per la terapia di complicanze neurologiche negli ammalati di aids.
US5332727A (en) * 1993-04-29 1994-07-26 Birkmayer U.S.A. Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
GB2341798B (en) * 1998-09-25 2001-03-14 Brian Whittle Associates Ltd Nutritional and pharmaceutical compositions comprising desiccants
IT1318535B1 (it) * 2000-05-25 2003-08-27 Chementecno Srl Processo per la preparazione di sali farmaceuticamente accettabili di(ss,rs)-s-adenosil-l-metionina.
US20020132780A1 (en) * 2001-01-12 2002-09-19 Heisey Matthew Thomas Low carbohydrate compositions, kits thereof, and methods of use
US20030069202A1 (en) * 2000-06-02 2003-04-10 Kern Kenneth Norman Compositions, kits, and methods for promoting defined health benefits
JP4346311B2 (ja) * 2001-04-27 2009-10-21 京都薬品工業株式会社 発泡性坐剤の保存方法
WO2002102823A1 (en) 2001-06-14 2002-12-27 Orchid Chemicals & Pharmaceuticals Limited Stable salts of s-adenosyl-l-methionine (same) and the process for their preparation
KR100927764B1 (ko) * 2001-08-10 2009-11-20 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 트레할로오스 또는 말티톨과 금속 이온 화합물과의 회합물(會合物)
ITMI20012462A1 (it) * 2001-11-22 2003-05-22 Gnosis Srl Processo per la preparazione di compresse comprendenti s-adenosilmetionina
US20040131805A1 (en) * 2002-06-20 2004-07-08 Merical Rick L. Films having a desiccant material incorporated therein and methods of use and manufacture
CA2539799A1 (en) 2003-09-22 2005-03-31 Nisshin Kyorin Pharmaceutical Co., Ltd. 5-aminosalicylic acid solid preparation improved in discoloration and method of storing the same
US20070298108A1 (en) * 2004-03-01 2007-12-27 Peter Svete Pharmaceutical Formulation
CN1663567A (zh) * 2004-03-05 2005-09-07 罗靖 复方甲硫氨酸维生素b1冻干粉针制剂及其制备方法
US8263574B2 (en) * 2004-09-29 2012-09-11 James L. Schaller, P.A. Topical formulations for the treatment of depression with S adenosyl methionine
ITRM20050344A1 (it) 2005-06-30 2007-01-01 Luca Maria De Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.
CN107072916A (zh) * 2014-11-10 2017-08-18 昭和电工株式会社 保湿剂

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115708820A (zh) * 2023-01-09 2023-02-24 广东科泰鼎润药业科技有限公司 L-茶氨酸缓释制剂、双释放制剂、应用和药物
CN115708820B (zh) * 2023-01-09 2023-06-02 广东科泰鼎润药业科技有限公司 L-茶氨酸缓释制剂、双释放制剂、应用和药物

Also Published As

Publication number Publication date
HRP20200315T1 (hr) 2020-06-12
BRPI0621556B1 (pt) 2020-09-29
RS20080441A (sr) 2009-07-15
IL194254A (en) 2015-07-30
BRPI0621556A2 (pt) 2012-10-09
US20150306126A1 (en) 2015-10-29
AU2006341243A1 (en) 2007-10-11
ES2774913T3 (es) 2020-07-23
CA2645767C (en) 2015-03-17
DK2007479T3 (da) 2020-02-24
NZ571240A (en) 2011-08-26
ZA200808118B (en) 2009-12-30
HUE047955T2 (hu) 2020-05-28
IL194254A0 (en) 2009-09-22
EP2007479A2 (en) 2008-12-31
WO2007113885A8 (en) 2008-11-13
MX2008012491A (es) 2009-03-02
EA017895B1 (ru) 2013-04-30
BRPI0621556B8 (pt) 2021-05-25
EP2007479B1 (en) 2019-12-04
SI2007479T1 (sl) 2020-04-30
ME00115B (me) 2010-10-10
PL2007479T3 (pl) 2020-09-21
RS59995B1 (sr) 2020-04-30
WO2007113885A2 (en) 2007-10-11
US20090110729A1 (en) 2009-04-30
AU2006341243B2 (en) 2012-02-23
WO2007113885A3 (en) 2008-01-24
JP2009532344A (ja) 2009-09-10
CA2645767A1 (en) 2007-10-11
EA200802095A1 (ru) 2009-02-27
US10471088B2 (en) 2019-11-12
CN101415464A (zh) 2009-04-22
CN101415464B (zh) 2013-10-30
MEP22708A (en) 2010-06-10
JP5562632B2 (ja) 2014-07-30

Similar Documents

Publication Publication Date Title
ITMI20060629A1 (it) Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
EP2100004A4 (en) HIGH STRENGTH ALLOYS
FR2932492B1 (fr) Compositions a base d'hydrofluoroolefines
FR2932493B1 (fr) Compositions a base d'hydrofluoroolefines
EP1890546A4 (en) COMPOSITION FOR INCREASING THE BIOLOGICAL AVAILABILITY OF CURCUMIN
DK1858488T3 (da) Tigecyclinsammensætninger samt fremstillingsfremgangsmåder
DE602006009851D1 (de) Schlagwerkzeug
FR2932494B1 (fr) Compositions a base d'hydrofluoroolefines
EP2024504A4 (en) PREPARATION OF ISOPRENOIDES
EP1746135A4 (en) HARDENING COMPOSITION
EP1818368A4 (en) HARDENING COMPOSITION
EP2025715A4 (en) HARDENING COMPOSITION
EP1923431A4 (en) Curable composition
DK1993370T3 (da) Forbedrede konfekturesammensætninger anvendende nanomaterialer
DE602007004820D1 (de) Härtbare Zusammensetzung
DE602007012648D1 (de) Härtbare Zusammensetzung
ZA200707070B (en) Analgesic compositions
DE602005015394D1 (de) Schlagwerkzeug
GB2443638B (en) An air-cooled aerofoil
ITRM20060108A1 (it) Composizioni a base di melatonina e sostanze immunostimolanti
EP2010379A4 (en) METALLIZED SHRIMPABLE LABEL
GB0413366D0 (en) Binder-free photopolymerizable compositions
EP1970411A4 (en) HARDENING COMPOSITION
DE602006010127D1 (de) Härtbare Zusammensetzung
ITMI20050817A1 (it) Processo di dealogenazione